Ionis Pharmaceuticals, Inc. Earnings

Ionis Pharmaceuticals, Inc.’s revenue fell -30.18% since last year same period to $226.58Mn in the Q4 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 69.09% jump in its revenue since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit fell -1026.51% since last year same period to $-104.35Mn in the Q4 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 25.72% jump in its net profits since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit margin fell -1513.41% since last year same period to -46.05% in the Q4 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 56.07% jump in its net profit margins since last 3-months.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.01 - a -19.61% fall from last quarter’s estimates.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.01.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) fell -617.33% since last year same period to -0.43 in the Q4 2024. This indicates that the Ionis Pharmaceuticals, Inc. has generated -617.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.